Yves Decadt
Vorstandsvorsitzender bei BioLingus (Cayman) Ltd.
Profil
Yves Decadt is the founder and currently serves as Chairman & Chief Executive Officer of BioLingus (Cayman) Ltd.
He previously held the position of Chief Executive Officer at Stragen Pharma SA. From 2015 to 2017, he was the Chief Executive Officer of MEDIMETRICS Personalized Drug Delivery BV.
Prior to that, he served as Director-Licensing & New Business Development at Johnson & Johnson and Johnson & Johnson AG from 2005 to 2010.
He also held the position of Vice President-Business Development at SkyePharma AG.
Mr. Decadt received his graduate degree from Ghent University and Université Libre de Bruxelles.
Mr. Decadt founded BioLingus (Cayman) Ltd.
in 2018.
Aktive Positionen von Yves Decadt
Unternehmen | Position | Beginn |
---|---|---|
BioLingus (Cayman) Ltd.
BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Vorstandsvorsitzender | 08.08.2018 |
Ehemalige bekannte Positionen von Yves Decadt
Unternehmen | Position | Ende |
---|---|---|
MEDIMETRICS Personalized Drug Delivery BV
MEDIMETRICS Personalized Drug Delivery BV Drugstore ChainsRetail Trade MEDIMETRICS Personalized Drug Delivery BV provides electronic oral drug delivery solutions. The firm develops IntelliCap system for precise delivery of drugs in the gastro-intestinal tract and the measurement and reporting of conditions in the body. The company was founded by Jeff Shimizu, Hans Zou and Olaf Weiner in 2011 and is headquartered in Eindhoven, Netherlands. | Vorstandsvorsitzender | 01.06.2017 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 01.07.2010 |
Johnson & Johnson AG
Johnson & Johnson AG Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Johnson & Johnson AG is a company that aims to transform healthcare for people around the world. The company is based in Spreitenbach, Switzerland. The Swiss company's focus is on making a difference in the lives of patients and their families. | Corporate Officer/Principal | 01.07.2010 |
SkyePharma AG | Corporate Officer/Principal | - |
Stragen Pharma SA
Stragen Pharma SA Pharmaceuticals: MajorHealth Technology Stragen Pharma SA is a Swiss pharmaceutical company that has been committed to the development of advanced generics since 1990. The company is based in Plan-les-Ouates, Switzerland, and has subsidiaries in Germany. The company focuses on innovation for health solutions and consistently operates under the latest quality standards to deliver Swiss tailor-made solutions for public health. Stragen offers a range of consumer health products with unique, natural formulas made from scientifically selected active ingredients. The company was founded in 1990, and the CEO is Jean-Luc Tétard. | Vorstandsvorsitzender | - |
Ausbildung von Yves Decadt
Ghent University | Graduate Degree |
Université Libre de Bruxelles | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 5 |
---|---|
SkyePharma AG | |
Johnson & Johnson AG
Johnson & Johnson AG Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Johnson & Johnson AG is a company that aims to transform healthcare for people around the world. The company is based in Spreitenbach, Switzerland. The Swiss company's focus is on making a difference in the lives of patients and their families. | Health Technology |
Stragen Pharma SA
Stragen Pharma SA Pharmaceuticals: MajorHealth Technology Stragen Pharma SA is a Swiss pharmaceutical company that has been committed to the development of advanced generics since 1990. The company is based in Plan-les-Ouates, Switzerland, and has subsidiaries in Germany. The company focuses on innovation for health solutions and consistently operates under the latest quality standards to deliver Swiss tailor-made solutions for public health. Stragen offers a range of consumer health products with unique, natural formulas made from scientifically selected active ingredients. The company was founded in 1990, and the CEO is Jean-Luc Tétard. | Health Technology |
MEDIMETRICS Personalized Drug Delivery BV
MEDIMETRICS Personalized Drug Delivery BV Drugstore ChainsRetail Trade MEDIMETRICS Personalized Drug Delivery BV provides electronic oral drug delivery solutions. The firm develops IntelliCap system for precise delivery of drugs in the gastro-intestinal tract and the measurement and reporting of conditions in the body. The company was founded by Jeff Shimizu, Hans Zou and Olaf Weiner in 2011 and is headquartered in Eindhoven, Netherlands. | Retail Trade |
BioLingus (Cayman) Ltd.
BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Commercial Services |